Announced
Completed
Financials
Tags
Acquisition
Friendly
Domestic
medical
Medical Services
Minority
Single Bidder
health care
biotechnology platform
technology platform
Venture Capital
Private
Completed
United States
Private Equity
Synopsis
DFJ Growth, an investment company, led a $40m Series B round in Osmind, a platform for breakthrough mental health research and treatment, with participation from Susa Ventures, Lachy Groom, Brent Saunders, Helena Goodman, Ariel Katz, General Catalyst, Future Ventures, Tiger Global, and Pear VC. “Osmind supports clinicians treating patients with serious and refractory mental health conditions, including severe depression, suicidality, PTSD, substance use disorders, anxiety, OCD, and more. By enabling the serious innovation being led by interventional mental health practices, we are doing our part to help researchers expand better, safer, more effective treatments for patients who need it most,” Jimmy Qian, Osmind Co-Founder and COO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.